Compare JOE & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JOE | STVN |
|---|---|---|
| Founded | 1936 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Homebuilding | Containers/Packaging |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2002 | 2021 |
| Metric | JOE | STVN |
|---|---|---|
| Price | $62.03 | $19.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 265.9K | ★ 267.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.93% | 0.39% |
| EPS Growth | ★ 56.69 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $513,246,000.00 | N/A |
| Revenue This Year | N/A | $9.67 |
| Revenue Next Year | N/A | $9.99 |
| P/E Ratio | $258.88 | ★ $27.15 |
| Revenue Growth | ★ 27.44 | N/A |
| 52 Week Low | $46.37 | $12.89 |
| 52 Week High | $73.54 | $28.00 |
| Indicator | JOE | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 57.51 |
| Support Level | $58.82 | $18.74 |
| Resistance Level | $62.94 | $20.27 |
| Average True Range (ATR) | 1.68 | 0.78 |
| MACD | 0.26 | -0.04 |
| Stochastic Oscillator | 77.42 | 55.63 |
The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.